Eiko LifeSciences Limited (BOM:540204)
India · Delayed Price · Currency is INR 46.65
+0.21 (0.45%)
At close: Aug 21, 2026
Eiko LifeSciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 44.96 | 21.06 | 7.52 | 7.69 | 7.06 |
Depreciation & Amortization | 10.16 | 7.37 | 6.63 | 6.33 | 5.62 |
Loss (Gain) From Sale of Assets | - | -0 | - | - | - |
Loss (Gain) From Sale of Investments | - | -0.15 | - | -0.32 | - |
Loss (Gain) on Equity Investments | -0.53 | - | - | - | - |
Other Operating Activities | 5.01 | -2.25 | 1.59 | -2.44 | -1.53 |
Change in Accounts Receivable | -94.32 | 23.48 | -60.28 | -25.43 | -11.48 |
Change in Inventory | 18.02 | -23.89 | -24.78 | 45.5 | -53.94 |
Change in Accounts Payable | 92.45 | 19.34 | 3.35 | -3.03 | -5.47 |
Change in Other Net Operating Assets | -52.92 | -15.72 | -4.82 | 13.94 | -17.54 |
Operating Cash Flow | 22.84 | 29.24 | -70.8 | 42.24 | -77.27 |
Operating Cash Flow Growth | -21.89% | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | - | -102.91 | -3.47 | -2.25 | -1.55 |
Investment in Securities | -80.87 | -31.22 | -39.64 | 2.1 | -0.03 |
Other Investing Activities | -5.75 | 19.69 | 37.62 | 8.89 | 6.42 |
Investing Cash Flow | -86.62 | -114.45 | -5.49 | 8.75 | 5.92 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 10.48 | 27.63 | - | - | 27.95 |
Total Debt Issued | 10.48 | 27.63 | - | - | 27.95 |
Long-Term Debt Repaid | - | - | - | -45.53 | - |
Total Debt Repaid | - | - | - | -45.53 | - |
Net Debt Issued (Repaid) | 10.48 | 27.63 | - | -45.53 | 27.95 |
Issuance of Common Stock | 74.94 | 43.46 | 205.05 | - | 9.5 |
Other Financing Activities | -3.3 | -1.54 | -1.42 | -1.5 | -4.64 |
Financing Cash Flow | 82.12 | 69.56 | 203.62 | -47.04 | 32.8 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | -0 | 0 | - |
Net Cash Flow | 18.34 | -15.65 | 127.34 | 3.95 | -38.55 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 22.84 | -73.67 | -74.26 | 39.99 | -78.82 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 4.33% | -19.56% | -26.59% | 21.83% | -31.02% |
Free Cash Flow Per Share | 1.62 | -5.65 | -7.20 | 4.09 | -10.09 |
Levered Free Cash Flow | 3.21 | -78.93 | -77.13 | 47.74 | -92.58 |
Unlevered Free Cash Flow | 5.27 | -77.97 | -76.25 | 48.67 | -90.27 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 3.3 | 1.59 | 1.42 | 1.5 | 4.64 |
Cash Income Tax Paid | 14.11 | 3.09 | 0.34 | -0.75 | 2.11 |
Change in Working Capital | -36.77 | 3.21 | -86.53 | 30.98 | -88.43 |